The impact of preadmission oral bisphosphonate use on 30-day mortality following stroke: a population-based cohort study of 100,043 patients
Conclusion: We found no overall evidence that preadmission bisphosphonate use increases 30-day mortality following stroke. Keywords: prognosis, oral bisphosphonates, stroke, mortality, cardiovascular disease, osteoporosis treatment
Source: Clinical Epidemiology - Category: Epidemiology Tags: Clinical Epidemiology Source Type: research
More News: Cardiology | Cardiovascular | Databases & Libraries | Endocrinology | Epidemiology | Heart | Hemorrhagic Stroke | Internal Medicine | Ischemic Stroke | Orthopaedics | Osteoporosis | Stroke | Study | Subarachnoid Hemorrhage